Frontlight ResearchEarly access
Active, not recruitingNo phase
Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study
Key facts
- Who runs it
- Abbott Medical Devices
- Where
- Georgia and Uzbekistan3 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 8 people enrolled
- Started
- 21 Nov 2024
- Expected to end
- Sept 2027
- Type of study
- Interventional
- Treatments tested
- Balloon expandable TAVI
- Record updated
- 8 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Increased surgical risk
- Appropriate anatomy
- At least 18 years of age
- Willing to return for follow-up assessments
Who cannot take part
- Inoperable/ineligible for surgery
- Anatomic or comorbid conditions
- Evidence of acute myocardial infarction
- Renal disease requiring chronic dialysis
- Pregnant or nursing subjects
Where is this trial?
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Early System Experience with the Abbott Balloon-expandable TAVI System
The group in the trial
- Balloon expandable TAVITreatment being tested
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- EASE Study: Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study
- Record updated
- 8 April 2026